The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care

(1) Background: We evaluated the clinical response of iguratimod (IGU) in patients with rheumatoid arthritis (RA) being treated with or without methotrexate (MTX) over 54 weeks. (2) Methods: 106 patients with RA undergoing IGU were retrospectively observed. RA patients were divided into those treate...

Full description

Bibliographic Details
Main Authors: Asuka Inoue, Yuji Nozaki, Yasuaki Hirooka, Koji Kinoshita, Yasutaka Chiba, Masanori Funauchi, Itaru Matsumura
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/10/11/261